ACT ENALAPRIL DIN 02291878
Status: Marketed
Holder: TEVA CANADA LIMITED
Molecule: ENALAPRIL SODIUM (ENALAPRIL MALEATE)
Available to quote
Health Canada record
| Active ingredient(s) | ENALAPRIL SODIUM (ENALAPRIL MALEATE) 2 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C09AA02 ENALAPRIL |
| Original market date | 17-Oct-2007 |
| Current status date | 18-Aug-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Teva Canada Limited — licence 101810, currently licensed, last inspection rating C (2025-03-04).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ENALAPRIL SODIUM (ENALAPRIL MALEATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02291886 | ACT ENALAPRIL | TEVA CANADA LIMITED | Tablet | ENALAPRIL SODIUM (ENALAPRIL MALEATE) 4 MG | Marketed |
| 02291908 | ACT ENALAPRIL | TEVA CANADA LIMITED | Tablet | ENALAPRIL SODIUM (ENALAPRIL MALEATE) 16 MG | Marketed |
| 02291894 | ACT ENALAPRIL | TEVA CANADA LIMITED | Tablet | ENALAPRIL SODIUM (ENALAPRIL MALEATE) 8 MG | Marketed |
| 02442981 | ENALAPRIL | SIVEM PHARMACEUTICALS ULC | Tablet | ENALAPRIL SODIUM (ENALAPRIL MALEATE) 16 MG | Marketed |
| 02442957 | ENALAPRIL | SIVEM PHARMACEUTICALS ULC | Tablet | ENALAPRIL SODIUM (ENALAPRIL MALEATE) 2 MG | Marketed |
| 02442965 | ENALAPRIL | SIVEM PHARMACEUTICALS ULC | Tablet | ENALAPRIL SODIUM (ENALAPRIL MALEATE) 4 MG | Marketed |
| 02442973 | ENALAPRIL | SIVEM PHARMACEUTICALS ULC | Tablet | ENALAPRIL SODIUM (ENALAPRIL MALEATE) 8 MG | Marketed |
| 00657298 | VASERETIC | ORGANON CANADA INC. | Tablet | ENALAPRIL SODIUM (ENALAPRIL MALEATE) 8 MG; HYDROCHLOROTHIAZIDE 25 MG | Marketed |
| 00708879 | VASOTEC | ORGANON CANADA INC. | Tablet | ENALAPRIL SODIUM (ENALAPRIL MALEATE) 4 MG | Marketed |
| 00670928 | VASOTEC | ORGANON CANADA INC. | Tablet | ENALAPRIL SODIUM (ENALAPRIL MALEATE) 16 MG | Marketed |
| 00670901 | VASOTEC | ORGANON CANADA INC. | Tablet | ENALAPRIL SODIUM (ENALAPRIL MALEATE) 8 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 19681 | 2017-08-18 | Abbreviated New Drug Submission (ANDS) | MERGER - BUYOUT |
| 15957 | 2014-08-15 | Abbreviated New Drug Submission (ANDS) | MANUFACTURER AND PRODUCT NAME CHANGE |
| 9126 | 2007-10-17 | Abbreviated New Drug Submission (ANDS) |